Novo Nordisk announced Monday that U.S. patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for ...

(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying ...

Two new studies raise questions about GLP-1 weight-loss drugs and vision risks. While findings show rare links to optic nerve damage and a slight rise in diabetic retinopathy, experts urge caution, ...